newsfilter
← Latest News
GlobeNewswire·

Aclarion Announces $2.5 Million Stock Repurchase Plan

BROOMFIELD, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company leveraging biomarkers and proprietary